
Future studies will help us determine who will most benefit from egg oral immunotherapy.
Future studies will help us determine who will most benefit from egg oral immunotherapy.
Creating your own new pharmacy, so that you can follow your passion and your dreams, can be very daunting.
Macleods Pharmaceuticals Limited has voluntarily recalled 1 lot of Losartan Potassium/Hydrochlorothiazide combination tablets 100mg/25mg to the consumer level, due to the detection of trace amounts of an unexpected impurity found in the product that is above the acceptable daily intake levels released by the FDA.
In the week ending Feb. 16, influenza was reported as widespread in 48 states and in Puerto Rico.
These products, from Mylan and Dr. Reddy’s Laboratories, are generic equivalents of Indivior PLC’s Suboxone sublingual film.1,2
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
The trial aimed to determine whether early intervention with Regeneron Pharmaceuticals' aflibercept injection (Eyelea) improved diabetic retinopathy severity and prevented serious vision-threatening complications.
Febuxostat was FDA-approved in 2009 to treat gout in adults.
Study findings also suggest a path forward to create even more effective flu vaccines.
Some may remember the old formulation of OTC Primatene Mist that was taken off the market in 2011 because it contained chlorofluorocarbon (CFC) propellants, which are known to deplete the ozone layer.
There is mixed evidence regarding the association between artificially sweetened beverages and the risk of cardiovascular disease adverse events.
Total Pharmacy™ is a unique platform to provide pharmacy professionals with the insight and resources to drive profitability while improving patient care.
High prices can negatively affect patient access and adherence.
A botanically-derived formula was found to heal cold sores in as little as 1 day.
The FDA’s acceptance of the application paves the way for an early review time.
Probiotics are misuderstood in their mechanisms of actions.
The new mobile app gives those with type 2 diabetes accurate insulin doses with an 'on-the-go' convenience.
A Senzer medical device for delivering pharmaceutical-grade cannabinoids has been granted ISO certification for Design and Development.
The needed-free treatment option, ARS-1, is designed to be easy-to-use, convenient and more reliable than other emergency epinephrine treatments for severe allergic reactions.
Non-steroidal anti-inflammatory drugs are now the most common therapeutic drug group for this group in the Golden State, according to a new study.
The FDA has approved the Biologics License Application for Novo Nordisk’s long-acting factor VIII replacement treatment for adults and children with hemophilia A.
Officials with the FDA have granted approval to Merck’s pembrolizumab (Keytruda) for the adjuvant treatment of melanoma with involvement of lymph node(s) following complete resection.
Officials with the FDA have approved Xellia Pharmaceuticals’ Premixed Vancomycin Injection in a Ready-to-Use (RTU) bag, according to the company.
We should all focus on the pharmacist and not the degree.
In this clip, Lee Golden, PharmD from TwelveStone Health in Tennesee shares how his love for running marathons and his passion for pharmacy require a similar mindset.
What is causing this young, healthy woman to lose her hair?
This study is the latest in a series that focuses on systematic accuracy in blood glucose test strip platforms.
Officials with the FDA have granted Priority Review to Merck’s supplemental Biologics License Application (sBLA) for pembrolizumab (Keytruda) for use in combination with axitinib (Inlyta, Pfizer) as first-line treatment for advanced renal cell carcinoma (RCC).
Writing in The Journal of Infectious Disease, they noted that pregnant women tend to be treated as high-priority patients when it comes to influenza prevention and treatment, but they said there is relatively little evidence clarifying exactly how outcomes differ for pregnant women versus nonpregnant women.